The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000634370
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
8/05/2026
Date registered
Help: Date registered
26/05/2026
Date last updated
Help: Date last updated
26/05/2026
Date data sharing statement initially provided
Help: Data sharing statement date
26/05/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Phase II clinical trial investigating the feasibility, acceptability, and preliminary efficacy of a Hub-and-Spoke, Peer-Led Community Aphasia Group program within a health service
Scientific title
Phase II Investigation of the feasibility, acceptability, and preliminary efficacy of a Hub-and-Spoke, Peer-Led Community Aphasia Group program within a health service
Additional trial identifiers [1] 317230 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
stroke 341834 0
aphasia 341835 0
Preventative health 341838 0
Condition category
Condition code
Neurological 337905 337905 0 0
Other neurological disorders
Stroke 338051 338051 0 0
Ischaemic
Stroke 338052 338052 0 0
Haemorrhagic
Public Health 338053 338053 0 0
Health service research

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
What is the intervention
This is a group-based intervention for people living with post-stroke aphasia in the community setting. Participants include people beyond 6-months post stroke aphasia, nominated close other. The program includes two separate interventions. A 12-week group program for participants with aphasia and a 3-week group program for nominated close others.

Who delivers it and their relevant expertise?

The community aphasia groups are facilitated by two volunteer facilitators, a peer with aphasia, and a community member without aphasia.

The volunteer facilitators are provided with formalised and scaffolded support from a clinical hub comprised of 4-5 allied and mental health clinicians.

Facilitation scaffolded support include:
1) Formal training delivered over two half-days and covering essential facilitation topics. This occurs at least two weeks prior to the delivery of the first session. Training is delivered by the Hub speech pathologist and Hub psychologist.
2) Clinicians input directly into the first four sessions of the program and assist with delivery of the group
3) Clinicians continue to consult with the volunteer facilitators over the 12-week program.
- Initial consultation occurs in the week prior to delivery of the first session and immediately after.
- Ongoing clinical support occurs in the form of a) The Hub-clinician obtains formal feedback from the volunteer facilitators at the end of each session, b) all Hub clinicians are available via email or phone to provide ad-hoc support on an as needs basis for the duration of the program.

The peer-support close other groups are facilitated by the Hub-speech therapist and the Hub-psychologist.

How it is delivered (e.g. face to face, online, group, individual)?

The aphasia group intervention is delivered face-to-face in the outpatient setting of the health service. The sessions run as 12 x 2hour sessions over 12 weeks.

The group intervention follows a modularised program with a different focus and objective for each session. Depending on the nature of the planned session participants are provided hard copy materials that have been designed specifically for the study. As outlined in the assessment section the volunteer facilitators maintain a participant attendance registry using an online Microsoft form which is completed immediately after session completion.

Session 1- Co facilitated with Hub-speech therapist. Objective: i) Establish group rules, ii) Supporting communication
Session 2- Co facilitated with Hub- psychology. Objective: i) Explore stroke experience and changes in identity
Session 3- Co facilitated with Hub- occupational therapy. Objective: i) Expression through movement, art, participation
Session 4- Co facilitated with Hub- Allied or mental health clinician. Objective i) Focus on health and wellbeing
Session 5- Facilitators with and without aphasia, with support from Hub-speech therapy. Objective i) Group choice making, ii) plan Weeks 6-12, iii) review group processes and roles
Session 6 to 11- Facilitators with and without aphasia, no hub input. Objective i) Follow plan set in Session 5
Session 12- Facilitators with and without aphasia, no hub input. Objective i) Celebrate 12-week program, ii) discuss future plans

The nominated close other participant group engage in an alternate intervention over three sessions. To assist attendance and reduce burden these sessions are scheduled to occur in parallel to the first three sessions of the community aphasia group. The close other sessions run for a duration of 2-hours and close other participants are provided both hard and soft copy materials to review at home. These include the "Aphasia Handbook" published by the Australian Aphasia Association and Stroke Foundation and the Connect Communication Disability Network "Aphasia Information Pack" as well as materials designed specifically for the study. A close-other participant attendance registry is maintained using an online Microsoft form which is completed immediately after session completion.

Session 1- close others attend the first community aphasia group with the members with aphasia. Objective: i) Establish relationships with broader group members, ii) Supporting communication
Session 2- Facilitated by Hub-speech therapy. Objective i) Promote supportive space for sharing experiences of aphasia, ii) review/learn communication styles and strategies, iii) engage in peer support
Session 3- Facilitated by Hub-psychologist. Objective i) Continue discussions of life with aphasia, ii) continue peer support, iii) strategies for maintaining wellbeing as a close other
Intervention code [1] 334003 0
Treatment: Other
Description of the comparator or control
The comparator is a waitlist control arm.

The waitlist control involves participants with aphasia after stroke and their nominated close other. The waitlist control group continue with usual care for the period of the intervention (12-weeks). During this time there is no therapy or treatment restrictions enforced by the protocol with the exception that they must suspend participation in other community aphasia group activity.

The waitlist control group are prompted to maintain an activity diary during the waitlist control period.

The activity diary is designed as an image-based menu. Participants review the categories on the menu and select their responses for each week of the 12-week program. Menu options span the ICF domains of body structures, activity and participation, environmental and include options such as, shopping, social activity, medical, therapy, gym, volunteering, working.

After the intervention group has completed the intervention and following completion of immediate post-12 weeks and 6-week follow-up, the waitlist control arm complete the intervention as outlined in the Description of the Intervention
Control group
Active

Outcomes
Primary outcome [1] 345355 0
The primary objective is to investigate the acceptability of the Hub-and-Spoke, Peer-led CAG program.
Timepoint [1] 345355 0
Acceptability rating on the 10-point VAS will be assessed immediately post intervention (Timepoint 2) for the intervention group and at Timepoint 4 immediately post the 12-week intervention for the waitlist control group. Assessment method 2 will be assessed at Timepoint 2 and Timepoint 4
Primary outcome [2] 345356 0
The primary objective is to investigate the feasibility of the Hub-and-Spoke, Peer-led CAG program.
Timepoint [2] 345356 0
Assessment method 1 will recorded at the close of recruitment- two weeks prior to intervention commencement.
Primary outcome [3] 345462 0
The primary objective is to investigate the acceptability of the Hub-and-Spoke, Peer-led CAG program.
Timepoint [3] 345462 0
Semi-structured interviews will be conducted immediately post intervention (Timepoint 2) for the intervention group and at Timepoint 4 immediately post the 12-week intervention for the waitlist control group.
Secondary outcome [1] 461383 0
The primary objective is to investigate the preliminary efficacy of the Hub-and-Spoke, Peer-led CAG program.
Timepoint [1] 461383 0
Assessments completed at: Baseline (T1), Immediately post completion of the 12-week intervention/ waitlist control period (T2), 6-week follow-up for both the intervention and waitlist control groups (T3), Immediately post-completion of the 12-week intervention for the waitlist control group (T4), and 6-week follow-up following waitlist control intervention completion (T5)
Secondary outcome [2] 461751 0
This is a primary outcome The primary objective is to investigate the feasibility of the Hub-and-Spoke, Peer-led CAG program.
Timepoint [2] 461751 0
Dropout rates will be recorded weekly via RedCap data management software across the intervention and control conditions until the completion of the study.
Secondary outcome [3] 461753 0
This is a primary outcome The primary objective is to investigate the feasibility of the Hub-and-Spoke, Peer-led CAG program.
Timepoint [3] 461753 0
15% of total sessions will be video recorded and re-watched and assessed using checklist based on key objectives of CAG training manual
Secondary outcome [4] 461757 0
This is a primary outcome The primary objective is to investigate the feasibility of the Hub-and-Spoke, Peer-led CAG program.
Timepoint [4] 461757 0
Participant attendance is recorded immediately post each session by the volunteer facilitators for each of the 12 group sessions in both the intervention and waitlist control groups.
Secondary outcome [5] 461759 0
This is a primary outcome The primary objective is to investigate the feasibility of the Hub-and-Spoke, Peer-led CAG program.
Timepoint [5] 461759 0
Outcome assessment completion rates will be measured at all timepoints ((T1) baseline, (T2) immediate post intervention/ waitlist control period, (T3) 6-week follow-up, (T4) immediate post waitlist control intervention, (T5) 6-week follow-up).
Secondary outcome [6] 461760 0
A secondary objective is to investigate the preliminary efficacy of the Hub-and-Spoke, Peer-led CAG program in relation to mental health & psychological well-being
Timepoint [6] 461760 0
Assessments completed at: Baseline (T1), Immediately post completion of the 12-week intervention/ waitlist control period (T2), 6-week follow-up for both the intervention and waitlist control groups (T3), Immediately post-completion of the 12-week intervention for the waitlist control group (T4), and 6-week follow-up following waitlist control intervention completion (T5)
Secondary outcome [7] 461761 0
A secondary objective is to investigate the preliminary efficacy of the Hub-and-Spoke, Peer-led CAG program in relation to severity of language impairment.
Timepoint [7] 461761 0
Assessments completed at: Baseline (T1), Immediately post completion of the 12-week intervention/ waitlist control period (T2), 6-week follow-up for both the intervention and waitlist control groups (T3), Immediately post-completion of the 12-week intervention for the waitlist control group (T4), and 6-week follow-up following waitlist control intervention completion (T5)
Secondary outcome [8] 461762 0
A secondary objective is to investigate the preliminary efficacy of the Hub-and-Spoke, Peer-led CAG program in relation to functional communication and use of multimodal communication.
Timepoint [8] 461762 0
Assessments completed at: Baseline (T1), Immediately post completion of the 12-week intervention/ waitlist control period (T2), 6-week follow-up for both the intervention and waitlist control groups (T3), Immediately post-completion of the 12-week intervention for the waitlist control group (T4), and 6-week follow-up following waitlist control intervention completion (T5)
Secondary outcome [9] 461763 0
A secondary objective is to investigate the preliminary efficacy of the Hub-and-Spoke, Peer-led CAG program in relation to functional communication and use of multimodal communication.
Timepoint [9] 461763 0
Assessments completed at: Baseline (T1), Immediately post completion of the 12-week intervention/ waitlist control period (T2), 6-week follow-up for both the intervention and waitlist control groups (T3), Immediately post-completion of the 12-week intervention for the waitlist control group (T4), and 6-week follow-up following waitlist control intervention completion (T5)
Secondary outcome [10] 461764 0
A secondary objective is to investigate the preliminary efficacy of the Hub-and-Spoke, Peer-led CAG program in relation to communication confidence.
Timepoint [10] 461764 0
Assessments completed at: Baseline (T1), Immediately post completion of the 12-week intervention/ waitlist control period (T2), 6-week follow-up for both the intervention and waitlist control groups (T3), Immediately post-completion of the 12-week intervention for the waitlist control group (T4), and 6-week follow-up following waitlist control intervention completion (T5)
Secondary outcome [11] 461765 0
A secondary objective is to investigate the preliminary efficacy of the Hub-and-Spoke, Peer-led CAG program in relation to community integration.
Timepoint [11] 461765 0
Assessments completed at: Baseline (T1), Immediately post completion of the 12-week intervention/ waitlist control period (T2), 6-week follow-up for both the intervention and waitlist control groups (T3), Immediately post-completion of the 12-week intervention for the waitlist control group (T4), and 6-week follow-up following waitlist control intervention completion (T5)
Secondary outcome [12] 461766 0
A secondary objective is to investigate the preliminary efficacy of the Hub-and-Spoke, Peer-led CAG program in relation to caregiver life changes.
Timepoint [12] 461766 0
Assessments completed at: Baseline (T1), Immediately post completion of the 12-week intervention/ waitlist control period (T2), 6-week follow-up for both the intervention and waitlist control groups (T3), Immediately post-completion of the 12-week intervention for the waitlist control group (T4), and 6-week follow-up following waitlist control intervention completion (T5)

Eligibility
Key inclusion criteria
Participants with aphasia will be included if they:
- have had a documented stroke resulting in aphasia
- the documented stroke occurred more than 4 months prior to baseline assessment (T1)
- Have a diagnosis of aphasia based on a score of less than 93.5 on the WAB-AQ assessment
- Were fluent in English prior to stroke
- Are 18 years or older at the time of consent
- Are able to give consent with appropriate accommodations
- Are able and willing to attend/ participate in baseline assessments, 12-week treatment period, post-intervention and follow-up assessment
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants will not be included if they:
- Have had a previous neurological event/diagnosis (head injury, neurosurgery, dementia, epilepsy, progressive neurological disorder) other than stroke,
- Have uncorrected sensory loss (hearing/vision) preventing participation in communication assessments and treatment group, and/or
- Are unable to attend the 6-week follow-up assessments.
- Have any other serious medical condition prior to their stroke including malignancies, psychiatric, behavioural or drug-dependency problems, which are likely to influence the participant's ability to cooperate or, in the opinion of the study investigator would prevent adherence to the protocol.
- Self-report or untreated major depressive disorder. As the intervention is not designed to specifically treat major depressive disorder, the individual will be guided to make an appointment with their General Practioner who can make appropriate onwards referrals.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation was concealed through central randomisation by computer
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Random order generation involved simple randomisation using a randomisation table created by computerised sequence generation.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
This is a Phase II, unpowered study. Four groups of six participants with chronic aphasia and four groups of six close others are randomised to two study arms. N=48 will be sufficient to establish feasibility of the program and investigate change over time.

Descriptive stats (Measures of Central Tendency and Dispersion) will be used to analysis quantitative data related to the Primary Outcomes of Acceptability and Feasibility. Generic thematic analysis and Content Analysis will be used to analyse qualitative data.

Repeated Measures Between Factors ANOVA (2 groups, 3 time points) will be used as a primary analysis for the Secondary Outcome of Preliminary Efficacy.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 29495 0
Ballarat Health Services - Queen Elizabeth Centre - Ballarat
Recruitment hospital [2] 29496 0
Ballarat Health Services (Base Hospital) - Ballarat Central
Recruitment postcode(s) [1] 45812 0
3350 - Ballarat
Recruitment postcode(s) [2] 45813 0
3350 - Ballarat Central

Funding & Sponsors
Funding source category [1] 321807 0
University
Name [1] 321807 0
La Trobe University
Country [1] 321807 0
Australia
Funding source category [2] 321811 0
Charities/Societies/Foundations
Name [2] 321811 0
Stroke Foundation
Country [2] 321811 0
Australia
Primary sponsor type
University
Name
La Trobe University
Address
Country
Australia
Secondary sponsor category [1] 324657 0
Government body
Name [1] 324657 0
Grampians Health
Address [1] 324657 0
Country [1] 324657 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320351 0
St John of God Health Care Human Research Ethics Committee
Ethics committee address [1] 320351 0
Ethics committee country [1] 320351 0
Australia
Date submitted for ethics approval [1] 320351 0
04/05/2023
Approval date [1] 320351 0
22/06/2023
Ethics approval number [1] 320351 0
97132

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150186 0
Dr Lucette Lanyon
Address 150186 0
La Trobe University, Discipline of Speech Pathology, School of Allied Health, Human Services and Sport, Kingsbury Drive, Bundoora, 3086
Country 150186 0
Australia
Phone 150186 0
+61 3 94792797
Fax 150186 0
Email 150186 0
Contact person for public queries
Name 150187 0
Lucette Lanyon
Address 150187 0
La Trobe University, Discipline of Speech Pathology, School of Allied Health, Human Services and Sport, Kingsbury Drive, Bundoora, VIC 3086
Country 150187 0
Australia
Phone 150187 0
+61 3 94792797
Fax 150187 0
Email 150187 0
Contact person for scientific queries
Name 150188 0
Lucette Lanyon
Address 150188 0
La Trobe University, Discipline of Speech Pathology, School of Allied Health, Human Services and Sport, Kingsbury Drive, Bundoora, VIC 3086
Country 150188 0
Australia
Phone 150188 0
+61 3 94792797
Fax 150188 0
Email 150188 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.